FDA Inspection 1174857 — James Benjamin Renfroe MD
The FDA completed an inspection of James Benjamin Renfroe MD on July 14, 2022 in Gulf Breeze, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 14, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gulf Breeze, FL (United States)
Additional Details
Clinical Investigator (CI)